-+ 0.00%
-+ 0.00%
-+ 0.00%

Jinhai Medical Technology (02225) announced interim results with revenue of SGD 34.21 million, a sharp increase of 134.16% year over year

Zhitongcaijing·08/27/2026 08:57:09
Listen to the news

According to the Zhitong Finance App, Jinhai Medical Technology (02225) announced interim results for the six months ended June 30, 2026. The Group's revenue was SGD 34.21 million, up 134.16% year on year; loss attributable to shareholders was SGD 4.362 million, a year-on-year narrowing of 57.46%; loss per share was 0.08 Singapore points.